Does Lineage Cell Therapeutics Inc (LCTX) Have What it Takes to be in Your Portfolio Monday?

Lineage Cell Therapeutics Inc (LCTX) is near the top in its industry group according to InvestorsObserver. LCTX gets an overall rating of 69. That means it scores higher than 69 percent of stocks. Lineage Cell Therapeutics Inc gets a 92 rank in the Biotechnology industry. Biotechnology is number 81 out of 148 industries.

LCTX has an Overall Score of 69. Find out what this means to you and get the rest of the rankings on LCTX!

See Full LCTX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 69 means the stock is more attractive than 69 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Lineage Cell Therapeutics Inc Stock Today?

Lineage Cell Therapeutics Inc (LCTX) stock has fallen -1.55% while the S&P 500 has risen 0.58% as of 9:36 AM on Monday, Oct 16. LCTX is lower by -$0.02 from the previous closing price of $1.29 on volume of 3,139 shares. Over the past year the S&P 500 is higher by 18.35% while LCTX has risen 17.59%. LCTX lost -$0.13 per share the over the last 12 months. Click Here to get the full Stock Report for Lineage Cell Therapeutics Inc stock.